Hancock Whitney Corp Charles River Laboratories International, Inc. Transaction History

Hancock Whitney Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $354,956 - $416,448	-3,615 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$100.43 - $118.09 $20,086 - $23,618	-200 Reduced 5.24%	3,615 $396,000
Q3 2017 Nov 14, 2017	SELL	$96.72 - $109.26 $175,159 - $197,869	-1,811 Reduced 32.19%	3,815 $412,000
Q2 2017 Aug 11, 2017	BUY	N/A	5,626	5,626 $569,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.